Bluejay Diagnostics, Inc.
BJDX
$1.94
$0.2414.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.81% | 35.51% | 12.01% | 8.32% | 3.50% |
| Total Depreciation and Amortization | -33.39% | -80.21% | -81.70% | -66.13% | -18.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,397.20% | 551.53% | 2,029.49% | -94.44% | -112.45% |
| Change in Net Operating Assets | 130.17% | -173.57% | -105.94% | 95.59% | 30.33% |
| Cash from Operations | 37.40% | -71.66% | -25.44% | 21.73% | 5.66% |
| Capital Expenditure | 98.75% | 99.73% | -34.26% | 89.61% | 63.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.75% | 99.73% | -34.26% | 89.61% | 63.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 23,966.67% | -30,866.67% | -159,466.67% | -300.00% | -50.00% |
| Issuance of Common Stock | -- | -99.97% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | 91.00% |
| Cash from Financing | 9,325.81% | -131.54% | 278,651.85% | 4,835.03% | -138.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.32% | -9,698.72% | 420.98% | 113.58% | 9.64% |